Litigation Details for ACTELION PHARMACEUTICALS LTD. v. SUN PHARMACEUTICAL INDUSTRIES, INC. (D.N.J. 2017)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2017-07-07
Court	District Court, D. New Jersey	Date Terminated	2019-08-21
Cause	15:1126 Patent Infringement	Assigned To	Peter G. Sheridan
Jury Demand	None	Referred To	Douglas Arpert
Parties	SUN PHARMACEUTICAL INDUSTRIES, INC.
Patents	8,318,802; 8,598,227
Attorneys	ANGELA CHERYL NI
Firms	Winston and Strawn LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-02-14	66		would result in United States Patent Number 8,318,802 (the ‘802 patent). (Harold Decl., Ex. G, Response…concerning United States Patent No. 8,598,227 (“227 patent”). The ‘227 patent is listed to market and …United States Patent, which ultimately issued as U.S. Patent No. 4,335,139 (“the Watts Patent”). (See Declaration…‘227 patent — in the ‘227 patent and its prosecution history, the ‘802 divisional patent and its…Harold Deci.), Ex. I, United States Patent No. 4,335,139). The Watts patent claims:	External link to document
2019-08-21	73	Order of Dismissal	infringement of United States Patent No. 8,598,227 ("the '227 patent"); Case 3:17-cv-05015…expiration of the '227 Patent, including any patent term extensions and/or patent term adjustments and…expiration of the '227 Patent was a technical act of patent infringement with respect to one…AND ORDER WHEREAS, this action for patent infringement ("the Litigation") was brought…certification" with respect to the '227 patent and seeking approval to engage in the commercial	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document